The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tuberculosis Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
The global Tuberculosis Vaccines market size is expected to reach US$ 90 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Vaccines in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Tuberculosis Vaccines market. Immunotherapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Booster Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tuberculosis Vaccines market, driven by demand from China, the second largest economy with some signs of stabilising, the Tuberculosis Vaccines market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Vaccines covered in this report include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals and Bavarian Nordic, etc.
The global Tuberculosis Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
Global Tuberculosis Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Vaccines market, Segment by Type:
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global Tuberculosis Vaccines market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tuberculosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
The global Tuberculosis Vaccines market size is expected to reach US$ 90 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis Vaccines in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Tuberculosis Vaccines market. Immunotherapeutic Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Booster Vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tuberculosis Vaccines market, driven by demand from China, the second largest economy with some signs of stabilising, the Tuberculosis Vaccines market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis Vaccines covered in this report include Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, IDT Biologics, GreenSignal Bio Pharma, Taj Pharmaceuticals and Bavarian Nordic, etc.
The global Tuberculosis Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
Global Tuberculosis Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis Vaccines market, Segment by Type:
Immunotherapeutic Vaccines
Booster Vaccines
Others
Global Tuberculosis Vaccines market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tuberculosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tuberculosis Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tuberculosis Vaccines Market Overview
1.1 Tuberculosis Vaccines Product Overview
1.2 Tuberculosis Vaccines Market Segment by Type
1.2.1 Immunotherapeutic Vaccines
1.2.2 Booster Vaccines
1.2.3 Others
1.3 Global Tuberculosis Vaccines Market Size by Type
1.3.1 Global Tuberculosis Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Tuberculosis Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tuberculosis Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tuberculosis Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tuberculosis Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tuberculosis Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tuberculosis Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tuberculosis Vaccines Sales Breakdown by Type (2018-2023)
2 Global Tuberculosis Vaccines Market Competition by Company
2.1 Global Top Players by Tuberculosis Vaccines Sales (2018-2023)
2.2 Global Top Players by Tuberculosis Vaccines Revenue (2018-2023)
2.3 Global Top Players by Tuberculosis Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Tuberculosis Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tuberculosis Vaccines Market Competitive Situation and Trends
2.5.1 Tuberculosis Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tuberculosis Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Tuberculosis Vaccines Market
2.8 Key Manufacturers Tuberculosis Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tuberculosis Vaccines Status and Outlook by Region
3.1 Global Tuberculosis Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tuberculosis Vaccines Historic Market Size by Region
3.2.1 Global Tuberculosis Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Tuberculosis Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Tuberculosis Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tuberculosis Vaccines Forecasted Market Size by Region
3.3.1 Global Tuberculosis Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Tuberculosis Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Tuberculosis Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tuberculosis Vaccines by Application
4.1 Tuberculosis Vaccines Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Tuberculosis Vaccines Market Size by Application
4.2.1 Global Tuberculosis Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Tuberculosis Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tuberculosis Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tuberculosis Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tuberculosis Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tuberculosis Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tuberculosis Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tuberculosis Vaccines Sales Breakdown by Application (2018-2023)
5 North America Tuberculosis Vaccines by Country
5.1 North America Tuberculosis Vaccines Historic Market Size by Country
5.1.1 North America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tuberculosis Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Tuberculosis Vaccines Sales in Value by Country (2018-2023)
5.2 North America Tuberculosis Vaccines Forecasted Market Size by Country
5.2.1 North America Tuberculosis Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Tuberculosis Vaccines Sales in Value by Country (2024-2029)
6 Europe Tuberculosis Vaccines by Country
6.1 Europe Tuberculosis Vaccines Historic Market Size by Country
6.1.1 Europe Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tuberculosis Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Tuberculosis Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Tuberculosis Vaccines Forecasted Market Size by Country
6.2.1 Europe Tuberculosis Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Tuberculosis Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Tuberculosis Vaccines by Region
7.1 Asia-Pacific Tuberculosis Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tuberculosis Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tuberculosis Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tuberculosis Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Tuberculosis Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tuberculosis Vaccines Sales in Value by Region (2024-2029)
8 Latin America Tuberculosis Vaccines by Country
8.1 Latin America Tuberculosis Vaccines Historic Market Size by Country
8.1.1 Latin America Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tuberculosis Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tuberculosis Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Tuberculosis Vaccines Forecasted Market Size by Country
8.2.1 Latin America Tuberculosis Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tuberculosis Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Tuberculosis Vaccines by Country
9.1 Middle East and Africa Tuberculosis Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Tuberculosis Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tuberculosis Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tuberculosis Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tuberculosis Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Tuberculosis Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tuberculosis Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Tuberculosis Vaccines Products Offered
10.1.5 Sanofi Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Tuberculosis Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 Japan BCG Lab
10.5.1 Japan BCG Lab Company Information
10.5.2 Japan BCG Lab Introduction and Business Overview
10.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
10.5.5 Japan BCG Lab Recent Development
10.6 IDT Biologics
10.6.1 IDT Biologics Company Information
10.6.2 IDT Biologics Introduction and Business Overview
10.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
10.6.5 IDT Biologics Recent Development
10.7 GreenSignal Bio Pharma
10.7.1 GreenSignal Bio Pharma Company Information
10.7.2 GreenSignal Bio Pharma Introduction and Business Overview
10.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
10.7.5 GreenSignal Bio Pharma Recent Development
10.8 Taj Pharmaceuticals
10.8.1 Taj Pharmaceuticals Company Information
10.8.2 Taj Pharmaceuticals Introduction and Business Overview
10.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
10.8.5 Taj Pharmaceuticals Recent Development
10.9 Bavarian Nordic
10.9.1 Bavarian Nordic Company Information
10.9.2 Bavarian Nordic Introduction and Business Overview
10.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
10.9.5 Bavarian Nordic Recent Development
10.10 China National Biotec Group
10.10.1 China National Biotec Group Company Information
10.10.2 China National Biotec Group Introduction and Business Overview
10.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
10.10.5 China National Biotec Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tuberculosis Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tuberculosis Vaccines Industrial Chain Analysis
11.4 Tuberculosis Vaccines Market Dynamics
11.4.1 Tuberculosis Vaccines Industry Trends
11.4.2 Tuberculosis Vaccines Market Drivers
11.4.3 Tuberculosis Vaccines Market Challenges
11.4.4 Tuberculosis Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tuberculosis Vaccines Distributors
12.3 Tuberculosis Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
